Clinical Trials Logo

Pregnancy clinical trials

View clinical trials related to Pregnancy.

Filter by:

NCT ID: NCT00685672 Completed - Pain Clinical Trials

Safety of Epidural Fentanyl and Adrenalin During Childbirth

Start date: August 2008
Phase: Phase 4
Study type: Interventional

Investigation of pharmacokinetic effects of combining fentanyl and adrenalin in the epidural solution given to women in childbirth

NCT ID: NCT00684606 Recruiting - Pregnancy Clinical Trials

Transcervical Foley Catheter With or Without Oxytocin for Induction of Labor

Start date: May 2008
Phase: N/A
Study type: Interventional

The purpose of the present study is to evaluate the possible benefit of concurrent IV Oxytocin infusion with trans cervical Foley catheter for pre-induction cervical ripening.

NCT ID: NCT00683202 Completed - Pregnancy Clinical Trials

Low-Dose Aspirin in in Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Treatments

Start date: March 2001
Phase: N/A
Study type: Interventional

In this study we hypothesized that low-dose aspirin therapy (100 mg daily) improves ovarian responsiveness, uterine haemodynamics and clinical pregnancy rates in unselected subjects undergoing IVF/ICSI when the treatment is started concomitantly with controlled ovarian hyperstimulation.

NCT ID: NCT00682201 Completed - Pregnancy Clinical Trials

Hemodynamic Changes During Normal Pregnancy

Start date: August 2007
Phase: N/A
Study type: Observational

Prospective, observational study of the changes in hemodynamic variables such as blood pressure, cardiac output, systemic vascular resistance, and of changes in respiratory variables such as vital capacity, and functional residual volume.A cohort study of 100 healthy pregnant women tested with non-invasive methods during pregnancy and 6 months after delivery.

NCT ID: NCT00669396 Completed - Pregnancy Clinical Trials

Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception

Start date: April 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to see if women presenting for emergency contraception (EC) are willing to accept the copper intrauterine device (IUD). This study will also compare the use of effective methods of contraception between women who selected the copper IUD or Plan B 6 months after they received EC.

NCT ID: NCT00654771 Completed - Hypertension Clinical Trials

Comparison of Catheterized and Clean Catch Urine Specimens for Protein/Creatinine Ratio in Preeclampsia Evaluation

UPREE
Start date: July 2005
Phase: N/A
Study type: Observational

The purpose of this prospective study was to examine whether protein/creatinine ratios in catheterized urine specimens correlate to clean catch specimens in pregnant patients being evaluated for preeclampsia.

NCT ID: NCT00647595 Completed - Obesity Clinical Trials

Effect of Physical Activity on Metabolic Syndrome in Pregnancy & Fetal Outcome

Start date: October 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the effect of exercise during pregnancy upon maternal metabolism, including weight gain, fat distribution, and levels of glucose and cholesterol. We will also conduct a pilot study to examine the feasibility of studying the health of infants born to women in this study.

NCT ID: NCT00646360 Completed - Pregnancy Clinical Trials

Effects of Prenatal DHA Supplements on Infant Development

Start date: February 2005
Phase: N/A
Study type: Interventional

This research study research is about the significance of polyunsaturated fatty acids (PUFAs) for human development. Specifically, the study team will assess the effect of docosahexanoic acid (DHA) supplementation during pregnancy on infant growth and development through a randomized controlled intervention trial in Cuernavaca, Mexico. This is a collaborative effort between the Rollins School of Public Health, Emory University, the Instituto Nacional de Salud Publica (INSP) and the Instituto Mexicano del Seguro Social (IMSS), Cuernavaca, Mexico. Pregnant women attending the IMSS General Hospital I are recruited between 18-22 weeks gestation and assigned randomly to receive either DHA (400 mg) or a placebo daily until delivery. The main study outcomes include a) birth outcomes: birth size, gestational age, cord blood levels of DHA and neurodevelopment b) maternal blood and breast milk DHA levels at 1 and 3 months post-partum, c) postnatal growth and development during the first 5 years of age and d) infant DHA status at 3, 12 and 18 months.

NCT ID: NCT00642980 Completed - Pregnancy Clinical Trials

Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis

PREMEVA
Start date: April 2006
Phase: Phase 4
Study type: Interventional

Background. Anomalies of the vaginal flora (bacterial vaginosis, BV) are associated with an increased risk of late abortions and preterm birth. Studies of antibiotic treatment of BV to reduce the risk of prematurity have not found a statistically significant diminution of risk (<= 32 wks: OR=0.49 [0.05-5.1], < 37 wks: OR=0.83 [0.59-1.17]).A partial explanation of these findings is that some of these treatment were administered vaginally, most often during the second or third trimester Aim: To reduce the frequency of late abortions and very preterm birth by prescribing clindamycin vs placebo to patients diagnosed with BV before 13 weeks.

NCT ID: NCT00642590 Active, not recruiting - Infertility Clinical Trials

Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy

Start date: March 2008
Phase: N/A
Study type: Observational

Researchers believe that certain lifestyle factors can influence a couple's ability to conceive and have a baby. The ISIS Study will look at the health habits of couples who are planning their first pregnancy, and then attempt to measure the effect these habits have on the couple's fertility. The ISIS Study hopes to clarify the link between lifestyle and fertility, and believes that information gained in this project may help future couples in their attempts to conceive.